Skip to the page

Data / Form D filings / Amptiv Biosciences, Inc.

Amptiv Biosciences, Inc.: Form D filings

Amptiv Biosciences, Inc., a health care company in Cleveland, OH, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on April 4, 2025, reports $300,000 sold of a $1.4 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11000 CEDAR AVE, STE 21, Cleveland, OH, 44106
Phone
(216) 220-4098
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2032327

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 4, 2025New notice$1,350,000$300,000$1,050,0003Mar 21, 2025sec.gov
Dec 31, 2024New notice$200,000$200,0001Dec 18, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jon ArmstrongDirector
Jonathan BellExecutive Officer, Director

Other health care companies in Ohio that filed recently

Every Form D from the week of Mar 31, 2025 · All recent filings in Ohio · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Amptiv Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.